Cyclerion Therapeutics,Inc. (CYCN)
US Market

Cyclerion Therapeutics Balance Sheet


Cyclerion Therapeutics Balance Sheet

Cyclerion Therapeutics's total assets for Q3 2022 were $25.05M, a decrease of -28.85% from the previous quarter. CYCN total liabilities were $8.53M for the fiscal quarter, a -13.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Assets
$ 59.33M$ 115.38M$ 186.48M$ 7.40M$ 5.47M
Total Liabilities
$ 11.09M$ 55.88M$ 88.75M$ 17.85M$ 14.04M
Total Equity Gross Minority
$ 48.25M$ 59.49M$ 97.73M$ -10.45M$ -8.57M
Total Capitalization
$ 48.25M$ 59.49M$ 97.73M$ -10.45M$ -8.57M
Preferred Stock Equity
Capital Lease Obligations
$ 0.00$ 42.23M$ 73.92M$ 0.00-
Currency in USD

Cyclerion Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis